ILMN Illumina Inc
Price (delayed)
$124.39
Market cap
$19.82B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$19.15
Enterprise value
$21.75B
Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a
Highlights
ILMN's net income has dropped by 136% since the previous quarter but it is up by 27% year-on-year
Illumina's EPS has shrunk by 135% QoQ but it has increased by 28% YoY
The equity has plunged by 78% YoY and by 75% from the previous quarter
The quick ratio has contracted by 37% from the previous quarter and by 26% YoY
Key stats
What are the main financial stats of ILMN
Market
Valuations
Earnings
Shares outstanding
159.3M
Market cap
$19.82B
Enterprise value
$21.75B
Price to book (P/B)
13.8
Price to sales (P/S)
4.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.91
Revenue
$4.43B
EBIT
-$2.96B
EBITDA
-$2.53B
Free cash flow
$357M
Per share
Balance sheet
Liquidity
EPS
-$19.15
Free cash flow per share
$2.25
Book value per share
$9.01
Revenue per share
$27.86
TBVPS
$29.71
Total assets
$6.08B
Total liabilities
$4.65B
Debt
$2.85B
Equity
$1.44B
Working capital
$251M
Debt to equity
1.98
Current ratio
1.11
Quick ratio
0.74
Net debt/EBITDA
-0.76
Margins
Efficiency
Dividend
EBITDA margin
-57.1%
Gross margin
62%
Net margin
-68.7%
Operating margin
-60.2%
Return on assets
-33.5%
Return on equity
-64.7%
Return on invested capital
-69.3%
Return on capital employed
-76.4%
Return on sales
-66.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ILMN stock price
How has the Illumina stock price performed over time
Intraday
-4.14%
1 week
-5.33%
1 month
6.9%
1 year
-22.25%
YTD
-10.67%
QTD
19.17%
Financial performance
How have Illumina's revenue and profit performed over time
Revenue
$4.43B
Gross profit
$2.75B
Operating income
-$2.67B
Net income
-$3.04B
Gross margin
62%
Net margin
-68.7%
Illumina's operating margin has plunged by 142% from the previous quarter but it has increased by 32% YoY
Illumina's net margin has shrunk by 139% QoQ but it has increased by 27% YoY
The operating income has plunged by 139% from the previous quarter but it has increased by 32% YoY
ILMN's net income has dropped by 136% since the previous quarter but it is up by 27% year-on-year
Growth
What is Illumina's growth rate over time
Valuation
What is Illumina stock price valuation
P/E
N/A
P/B
13.8
P/S
4.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.91
Illumina's EPS has shrunk by 135% QoQ but it has increased by 28% YoY
The price to book (P/B) is 142% higher than the last 4 quarters average of 5.7 and 86% higher than the 5-year quarterly average of 7.4
The equity has plunged by 78% YoY and by 75% from the previous quarter
ILMN's P/S is 57% below its 5-year quarterly average of 10.5 and 2.8% below its last 4 quarters average of 4.6
Efficiency
How efficient is Illumina business performance
Illumina's return on sales has shrunk by 179% QoQ but it has increased by 25% YoY
ILMN's return on invested capital has dropped by 176% since the previous quarter but it is up by 26% year-on-year
The company's return on assets has shrunk by 172% QoQ but it rose by 6% YoY
The ROE has contracted by 2.7% YoY
Dividends
What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ILMN.
Financial health
How did Illumina financials performed over time
The total assets is 31% more than the total liabilities
The total assets has contracted by 48% YoY and by 39% from the previous quarter
The quick ratio has contracted by 37% from the previous quarter and by 26% YoY
Illumina's debt is 98% higher than its equity
The equity has plunged by 78% YoY and by 75% from the previous quarter
Illumina's debt has increased by 30% QoQ but it has decreased by 3.8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.